CClinicalTrials.gg
Active, not recruitingNCT07440979Updated Mar 6, 2026

Personalized Nutrition Coaching for a Weight Loss Program Among Overweight and Obese Nurses

An interventional study of Personalized Nutrition Coaching and Control (placebo) group in Obesity & Overweight, Healthcare Worker and Low Physical Activity Level, sponsored by Universitas Padjadjaran. Active, not recruiting at 1 site in Indonesia. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Universitas Padjadjaran · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Obesity among healthcare workers has become an increasing public health concern, with potential consequences for work productivity, quality of care, and long-term health outcomes. Despite their role in promoting health, healthcare workers often face demanding schedules, high stress levels, and limited access to structured health promotion programs, placing them at elevated risk for overweight and obesity. In the absence of targeted workplace interventions, these conditions may persist and worsen over time, highlighting the need for effective, sustainable, and context-specific strategies to support healthier lifestyles among healthcare workers.

This study aims to assess the effectiveness of personalized nutrition coaching as part of a weight loss program for Nurses in Indonesian Hospital. Participants who receive the intervention are expected to demonstrate improvements in nutritional status, including weight-related outcomes, reduction in body fat percentage, reduction in waist circumference. The intervention is also anticipated to promote healthier dietary intake, characterized by more balanced eating patterns, and higher levels of physical activity. Delivered through individualized online guidance, this program is intended to encourage sustainable lifestyle changes and improve overall health. The study will involve an 8-week intervention conducted among overweight and obese healthcare workers at Dr. Hasan Sadikin General Hospital, Bandung.

02

Conditions studied

  • Obesity & Overweight
  • Healthcare Worker
  • Low Physical Activity Level

Keywords

  • Weight Loss Program
  • Healthcare Worker
  • Obesity
  • Overweight
  • Hospital
  • BMI
  • Physical Activity
  • Energy Intake
  • Waist Circumference
  • Body Fat Percentage
  • Weight
  • Nutrition Coaching
  • Personalized Nutrition
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.

This study's planned enrollment of 44 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Universitas Padjadjaran is the lead sponsor of 90 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • A Shift Nurse in Dr. Hasan Sadikin General Hospital Bandung
  • Male and Female, Aged 18-35 years (Young Adult)
  • Overweight (body mass index 23.0-24.99 kg/m²) or obese (body mass index ≥25.0 kg/m²)
  • Willing to participate in the study and provide written informed consent
  • Ownership of a smartphone and access to the internet

Exclusion criteria

Exclusion Criteria:

  • Being pregnant and/or breastfeeding.
  • Currently participating in a calorie-restricted diet program
  • Having special conditions such as food allergies, sensitivities, or intolerances, or following a specific dietary pattern (e.g., vegan diet or carbohydrate-restricted diet)
  • Having a recent diagnosis or condition that may interfere with study outcomes (body weight, body fat percentage, waist circumference), such as edema or smoking cessation within the past 3 months
  • Taking medications that may affect the study outcomes
  • Having diseases requiring dietary restriction or specialized Medical Nutrition Therapy (MNT), such as diabetes mellitus, kidney disease, or stroke
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Personalized Nutrition Coaching

    The intervention group consists 22 of Overweight and Obese Healthcare Workers who receive nutrition counseling and personalized nutrition coaching

    Behavioral: Personalized Nutrition Coaching

  • Placebo comparator
    Control

    The control group consists of 22 of Overweight and Obese Healthcare Workers who receive nutrition education in the form of a booklet. The booklet provides information on basic balanced nutrition guidelines

    Other: Control (placebo) group

Interventions

  • BehavioralPersonalized Nutrition Coaching

    The intervention arm received 8 weeks of personalized nutrition coaching. During the intervention period, participants were provided with frequent follow-up through the WhatsApp application to discuss progress with a dietitian. In addition, scheduled follow-up counseling sessions were conducted via Zoom in week 3 and week 6 to evaluate the progress Participants in the intervention group were also provided with a personalized meal plan, tailored to individual daily energy requirements, food preferences, and recommended menu options. Throughout the monitoring period, body weight was assessed weekly, while dietary intake was monitored three times per week on nonconsecutive days to evaluate adherence to the meal plan. Physical activity was monitored weekly using self reported physical activity using Standford 7 days Physical Activity Recall Questionnaire

  • OtherControl (placebo) group

    The control group will receive nutrition education in the form of a booklet. The booklet provides information on balanced nutrition guidelines, recognizing hunger and satiety cues, mindful eating practices, and recommendations for physical activity.

06

What researchers measure

Primary outcomes

  1. Body weight (BW)

    Body mass of the participant measured in kilograms. (i.e., at least 5% of baseline body weight)

    Time frame: 8 weeks

Secondary outcomes

  1. Height

    Height in centimeters, measured using stadiometer

    Time frame: 8 weeks

  2. Waist circumference (WC)

    Circumference of the waist measured in centimeters.

    Time frame: 8 weeks

  3. Body fat percentage

    Percentage of fat mass relative to total body mass.

    Time frame: 8 weeks

  4. Dietary intake

    Amount of energy and macronutrients consumed by the participant. Estimated 3×24-hour food record. Energy (kcal), protein (g), fat (g), carbohydrates (g), fiber (g)

    Time frame: 8 weeks

  5. Physical activity

    Total METs (Metabolic Equivalent) in minutes per week of Moderate-Vigorous Physical Activity (MVPA) performed by the participant. Method: self reported using 7-Day Physical Activity Recall Questionnaire (PAR-Q)

    Time frame: 8 weeks

07

Study locations

1 site
  • Dr. Hasan Sadikin General Hospital Bandung
    Bandung, West Java 40161, Indonesia
08

References and documents

Individual participant data

Plan to share: No — The ethics committee requests for the IPD not to be shared and keep the subject's confidential

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07440979
Lead sponsor
Universitas Padjadjaran
Responsible party
Tazkiah Syahidah (Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Indonesia, Universitas Padjadjaran) — Principal investigator
First posted
Feb 27, 2026
Start date
Jan 19, 2026
Primary completion
Mar 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Mar 6, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion